nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—Mouth ulceration—Mercaptopurine—Crohn's disease	0.0259	0.0282	CcSEcCtD
Darifenacin—Breast disorder—Mercaptopurine—Crohn's disease	0.0188	0.0204	CcSEcCtD
Darifenacin—Cough increased—Mesalazine—Crohn's disease	0.017	0.0185	CcSEcCtD
Darifenacin—Stomatitis—Mercaptopurine—Crohn's disease	0.0156	0.017	CcSEcCtD
Darifenacin—Vaginal inflammation—Mesalazine—Crohn's disease	0.0155	0.0169	CcSEcCtD
Darifenacin—Vaginal infection—Mesalazine—Crohn's disease	0.0147	0.016	CcSEcCtD
Darifenacin—Dry eye—Mesalazine—Crohn's disease	0.0143	0.0156	CcSEcCtD
Darifenacin—Mouth ulceration—Mesalazine—Crohn's disease	0.014	0.0153	CcSEcCtD
Darifenacin—Bladder pain—Mesalazine—Crohn's disease	0.014	0.0153	CcSEcCtD
Darifenacin—Face oedema—Mesalazine—Crohn's disease	0.0109	0.0119	CcSEcCtD
Darifenacin—Arthralgia—Mercaptopurine—Crohn's disease	0.0106	0.0116	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0106	0.0115	CcSEcCtD
Darifenacin—Dry skin—Mesalazine—Crohn's disease	0.0103	0.0113	CcSEcCtD
Darifenacin—Oedema—Mercaptopurine—Crohn's disease	0.0102	0.0111	CcSEcCtD
Darifenacin—Breast disorder—Mesalazine—Crohn's disease	0.0102	0.0111	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.0101	0.0111	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00994	0.0108	CcSEcCtD
Darifenacin—Skin disorder—Mercaptopurine—Crohn's disease	0.00991	0.0108	CcSEcCtD
Darifenacin—Influenza—Mesalazine—Crohn's disease	0.00974	0.0106	CcSEcCtD
Darifenacin—Infestation NOS—Azathioprine—Crohn's disease	0.00953	0.0104	CcSEcCtD
Darifenacin—Infestation—Azathioprine—Crohn's disease	0.00953	0.0104	CcSEcCtD
Darifenacin—Bronchitis—Mesalazine—Crohn's disease	0.00936	0.0102	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00929	0.0101	CcSEcCtD
Darifenacin—Weight increased—Mesalazine—Crohn's disease	0.00886	0.00966	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00881	0.0096	CcSEcCtD
Darifenacin—Infestation NOS—Mesalazine—Crohn's disease	0.00868	0.00946	CcSEcCtD
Darifenacin—Infestation—Mesalazine—Crohn's disease	0.00868	0.00946	CcSEcCtD
Darifenacin—Stomatitis—Mesalazine—Crohn's disease	0.00846	0.00922	CcSEcCtD
Darifenacin—Urinary tract infection—Mesalazine—Crohn's disease	0.00844	0.0092	CcSEcCtD
Darifenacin—Sweating—Mesalazine—Crohn's disease	0.00832	0.00907	CcSEcCtD
Darifenacin—Sinusitis—Mesalazine—Crohn's disease	0.00814	0.00888	CcSEcCtD
Darifenacin—Erythema multiforme—Azathioprine—Crohn's disease	0.00809	0.00882	CcSEcCtD
Darifenacin—Rhinitis—Mesalazine—Crohn's disease	0.00781	0.00851	CcSEcCtD
Darifenacin—Pharyngitis—Mesalazine—Crohn's disease	0.00773	0.00843	CcSEcCtD
Darifenacin—Mediastinal disorder—Azathioprine—Crohn's disease	0.00771	0.0084	CcSEcCtD
Darifenacin—Urinary tract disorder—Mesalazine—Crohn's disease	0.0077	0.00839	CcSEcCtD
Darifenacin—Oedema peripheral—Mesalazine—Crohn's disease	0.00768	0.00837	CcSEcCtD
Darifenacin—Urethral disorder—Mesalazine—Crohn's disease	0.00764	0.00832	CcSEcCtD
Darifenacin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00752	0.00819	CcSEcCtD
Darifenacin—Erythema multiforme—Mesalazine—Crohn's disease	0.00737	0.00803	CcSEcCtD
Darifenacin—Eye disorder—Mesalazine—Crohn's disease	0.00728	0.00794	CcSEcCtD
Darifenacin—Angiopathy—Mesalazine—Crohn's disease	0.00707	0.00771	CcSEcCtD
Darifenacin—Mediastinal disorder—Mesalazine—Crohn's disease	0.00702	0.00765	CcSEcCtD
Darifenacin—Diarrhoea—Mercaptopurine—Crohn's disease	0.00698	0.00761	CcSEcCtD
Darifenacin—Mental disorder—Mesalazine—Crohn's disease	0.00683	0.00744	CcSEcCtD
Darifenacin—Flatulence—Mesalazine—Crohn's disease	0.00668	0.00728	CcSEcCtD
Darifenacin—Dysgeusia—Mesalazine—Crohn's disease	0.00664	0.00724	CcSEcCtD
Darifenacin—Back pain—Mesalazine—Crohn's disease	0.00656	0.00715	CcSEcCtD
Darifenacin—Vomiting—Mercaptopurine—Crohn's disease	0.00649	0.00707	CcSEcCtD
Darifenacin—Injury—Prednisone—Crohn's disease	0.00648	0.00707	CcSEcCtD
Darifenacin—Rash—Mercaptopurine—Crohn's disease	0.00643	0.00701	CcSEcCtD
Darifenacin—Dermatitis—Mercaptopurine—Crohn's disease	0.00643	0.007	CcSEcCtD
Darifenacin—Vision blurred—Mesalazine—Crohn's disease	0.00639	0.00697	CcSEcCtD
Darifenacin—Arthralgia—Azathioprine—Crohn's disease	0.00634	0.00691	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0063	0.00686	CcSEcCtD
Darifenacin—Angioedema—Mesalazine—Crohn's disease	0.0062	0.00676	CcSEcCtD
Darifenacin—Syncope—Mesalazine—Crohn's disease	0.00608	0.00663	CcSEcCtD
Darifenacin—Nausea—Mercaptopurine—Crohn's disease	0.00606	0.0066	CcSEcCtD
Darifenacin—Infection—Azathioprine—Crohn's disease	0.00604	0.00658	CcSEcCtD
Darifenacin—Palpitations—Mesalazine—Crohn's disease	0.006	0.00653	CcSEcCtD
Darifenacin—Loss of consciousness—Mesalazine—Crohn's disease	0.00596	0.0065	CcSEcCtD
Darifenacin—Cough—Mesalazine—Crohn's disease	0.00592	0.00645	CcSEcCtD
Darifenacin—Skin disorder—Azathioprine—Crohn's disease	0.0059	0.00643	CcSEcCtD
Darifenacin—Hypertension—Mesalazine—Crohn's disease	0.00586	0.00638	CcSEcCtD
Darifenacin—Arthralgia—Mesalazine—Crohn's disease	0.00578	0.00629	CcSEcCtD
Darifenacin—Face oedema—Prednisone—Crohn's disease	0.00575	0.00627	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00574	0.00625	CcSEcCtD
Darifenacin—Dry mouth—Mesalazine—Crohn's disease	0.00565	0.00616	CcSEcCtD
Darifenacin—Confusional state—Mesalazine—Crohn's disease	0.00558	0.00608	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00554	0.00603	CcSEcCtD
Darifenacin—Oedema—Mesalazine—Crohn's disease	0.00554	0.00603	CcSEcCtD
Darifenacin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00554	0.00603	CcSEcCtD
Darifenacin—Infection—Mesalazine—Crohn's disease	0.0055	0.00599	CcSEcCtD
Darifenacin—Dry skin—Prednisone—Crohn's disease	0.00546	0.00595	CcSEcCtD
Darifenacin—Shock—Mesalazine—Crohn's disease	0.00545	0.00594	CcSEcCtD
Darifenacin—Nervous system disorder—Mesalazine—Crohn's disease	0.00543	0.00592	CcSEcCtD
Darifenacin—Tachycardia—Mesalazine—Crohn's disease	0.0054	0.00589	CcSEcCtD
Darifenacin—Skin disorder—Mesalazine—Crohn's disease	0.00538	0.00586	CcSEcCtD
Darifenacin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00535	0.00583	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00526	0.00573	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00525	0.00572	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00504	0.0055	CcSEcCtD
Darifenacin—Feeling abnormal—Azathioprine—Crohn's disease	0.00501	0.00546	CcSEcCtD
Darifenacin—Insomnia—Mesalazine—Crohn's disease	0.00501	0.00546	CcSEcCtD
Darifenacin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00497	0.00542	CcSEcCtD
Darifenacin—Dyspnoea—Mesalazine—Crohn's disease	0.00494	0.00538	CcSEcCtD
Darifenacin—Somnolence—Mesalazine—Crohn's disease	0.00492	0.00536	CcSEcCtD
Darifenacin—Dyspepsia—Mesalazine—Crohn's disease	0.00487	0.00531	CcSEcCtD
Darifenacin—Abdominal pain—Azathioprine—Crohn's disease	0.00481	0.00524	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00478	0.00521	CcSEcCtD
Darifenacin—Erectile dysfunction—Prednisone—Crohn's disease	0.00474	0.00517	CcSEcCtD
Darifenacin—Pain—Mesalazine—Crohn's disease	0.00473	0.00516	CcSEcCtD
Darifenacin—Constipation—Mesalazine—Crohn's disease	0.00473	0.00516	CcSEcCtD
Darifenacin—Weight increased—Prednisone—Crohn's disease	0.00469	0.00511	CcSEcCtD
Darifenacin—Feeling abnormal—Mesalazine—Crohn's disease	0.00456	0.00497	CcSEcCtD
Darifenacin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00453	0.00493	CcSEcCtD
Darifenacin—Hypersensitivity—Azathioprine—Crohn's disease	0.00448	0.00488	CcSEcCtD
Darifenacin—Abdominal pain—Mesalazine—Crohn's disease	0.00438	0.00477	CcSEcCtD
Darifenacin—Diarrhoea—Azathioprine—Crohn's disease	0.00416	0.00453	CcSEcCtD
Darifenacin—Hallucination—Prednisone—Crohn's disease	0.0041	0.00447	CcSEcCtD
Darifenacin—Hypersensitivity—Mesalazine—Crohn's disease	0.00408	0.00445	CcSEcCtD
Darifenacin—Dizziness—Azathioprine—Crohn's disease	0.00402	0.00438	CcSEcCtD
Darifenacin—Asthenia—Mesalazine—Crohn's disease	0.00397	0.00433	CcSEcCtD
Darifenacin—Pruritus—Mesalazine—Crohn's disease	0.00392	0.00427	CcSEcCtD
Darifenacin—Vomiting—Azathioprine—Crohn's disease	0.00386	0.00421	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—Crohn's disease	0.00385	0.0042	CcSEcCtD
Darifenacin—Rash—Azathioprine—Crohn's disease	0.00383	0.00418	CcSEcCtD
Darifenacin—Dermatitis—Azathioprine—Crohn's disease	0.00383	0.00417	CcSEcCtD
Darifenacin—Headache—Azathioprine—Crohn's disease	0.00381	0.00415	CcSEcCtD
Darifenacin—Diarrhoea—Mesalazine—Crohn's disease	0.00379	0.00413	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—Crohn's disease	0.00374	0.00408	CcSEcCtD
Darifenacin—Dizziness—Mesalazine—Crohn's disease	0.00366	0.00399	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—Crohn's disease	0.00361	0.00394	CcSEcCtD
Darifenacin—Nausea—Azathioprine—Crohn's disease	0.00361	0.00393	CcSEcCtD
Darifenacin—Vomiting—Mesalazine—Crohn's disease	0.00352	0.00384	CcSEcCtD
Darifenacin—Rash—Mesalazine—Crohn's disease	0.00349	0.0038	CcSEcCtD
Darifenacin—Dermatitis—Mesalazine—Crohn's disease	0.00349	0.0038	CcSEcCtD
Darifenacin—Headache—Mesalazine—Crohn's disease	0.00347	0.00378	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—Crohn's disease	0.00338	0.00369	CcSEcCtD
Darifenacin—Nausea—Mesalazine—Crohn's disease	0.00329	0.00358	CcSEcCtD
Darifenacin—Angioedema—Prednisone—Crohn's disease	0.00328	0.00357	CcSEcCtD
Darifenacin—Syncope—Prednisone—Crohn's disease	0.00322	0.00351	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—Crohn's disease	0.00315	0.00344	CcSEcCtD
Darifenacin—Hypertension—Prednisone—Crohn's disease	0.0031	0.00338	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—Crohn's disease	0.00306	0.00333	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00303	0.00331	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—Crohn's disease	0.00293	0.00319	CcSEcCtD
Darifenacin—Oedema—Prednisone—Crohn's disease	0.00293	0.00319	CcSEcCtD
Darifenacin—Infection—Prednisone—Crohn's disease	0.00291	0.00317	CcSEcCtD
Darifenacin—Shock—Prednisone—Crohn's disease	0.00288	0.00314	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—Crohn's disease	0.00287	0.00313	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—Crohn's disease	0.00286	0.00312	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—Crohn's disease	0.00285	0.0031	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—Crohn's disease	0.00283	0.00309	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00267	0.00291	CcSEcCtD
Darifenacin—Insomnia—Prednisone—Crohn's disease	0.00265	0.00289	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—Crohn's disease	0.00258	0.00281	CcSEcCtD
Darifenacin—Constipation—Prednisone—Crohn's disease	0.00251	0.00273	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—Crohn's disease	0.00241	0.00263	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—Crohn's disease	0.0024	0.00261	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—Crohn's disease	0.00232	0.00252	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—Crohn's disease	0.00216	0.00235	CcSEcCtD
Darifenacin—Asthenia—Prednisone—Crohn's disease	0.0021	0.00229	CcSEcCtD
Darifenacin—Pruritus—Prednisone—Crohn's disease	0.00207	0.00226	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—Crohn's disease	0.002	0.00218	CcSEcCtD
Darifenacin—Dizziness—Prednisone—Crohn's disease	0.00194	0.00211	CcSEcCtD
Darifenacin—Vomiting—Prednisone—Crohn's disease	0.00186	0.00203	CcSEcCtD
Darifenacin—Rash—Prednisone—Crohn's disease	0.00185	0.00201	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—Crohn's disease	0.00185	0.00201	CcSEcCtD
Darifenacin—Headache—Prednisone—Crohn's disease	0.00184	0.002	CcSEcCtD
Darifenacin—Nausea—Prednisone—Crohn's disease	0.00174	0.0019	CcSEcCtD
Darifenacin—CHRM4—Signaling Pathways—MLN—Crohn's disease	0.000203	0.00247	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MLN—Crohn's disease	0.000195	0.00237	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000194	0.00235	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TAGAP—Crohn's disease	0.000186	0.00226	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000185	0.00224	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000183	0.00222	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.000182	0.00221	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.000181	0.00219	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	0.000178	0.00216	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000177	0.00215	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.000177	0.00215	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.000175	0.00212	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CCR6—Crohn's disease	0.000174	0.00211	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	0.000167	0.00202	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000165	0.002	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.000164	0.00199	CbGpPWpGaD
Darifenacin—CHRM4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000164	0.00199	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.000163	0.00198	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RSPO3—Crohn's disease	0.000163	0.00197	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000161	0.00195	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.00016	0.00195	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.000159	0.00193	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CCR6—Crohn's disease	0.000158	0.00192	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	0.000156	0.00189	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SEL1L—Crohn's disease	0.000154	0.00187	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PTGER4—Crohn's disease	0.000153	0.00186	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000151	0.00184	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	0.000151	0.00184	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.00015	0.00182	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.00015	0.00182	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000149	0.00181	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000148	0.00179	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	0.000148	0.00179	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	0.000147	0.00178	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000145	0.00176	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000145	0.00176	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000144	0.00175	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000143	0.00173	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR9—Crohn's disease	0.000141	0.00171	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PTGER4—Crohn's disease	0.000139	0.00169	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000137	0.00167	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000137	0.00166	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000136	0.00166	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000136	0.00165	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000135	0.00164	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR9—Crohn's disease	0.000135	0.00164	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	0.000133	0.00162	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GPR65—Crohn's disease	0.000131	0.00159	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL3—Crohn's disease	0.000131	0.00159	CbGpPWpGaD
Darifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00013	0.00158	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00013	0.00158	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00013	0.00157	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTMR3—Crohn's disease	0.000127	0.00154	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000126	0.00153	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GPR65—Crohn's disease	0.000126	0.00152	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000125	0.00152	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.000125	0.00152	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	0.000125	0.00152	CbGpPWpGaD
Darifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000125	0.00152	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000124	0.0015	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000121	0.00147	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL3—Crohn's disease	0.000119	0.00144	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000117	0.00143	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000117	0.00142	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.000116	0.00141	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000115	0.00139	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL3—Crohn's disease	0.000114	0.00138	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	0.00011	0.00133	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00011	0.00133	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000109	0.00133	CbGpPWpGaD
Darifenacin—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000109	0.00133	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000108	0.00131	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000107	0.00129	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.000106	0.00129	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000105	0.00128	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000105	0.00128	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000104	0.00126	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000104	0.00126	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000103	0.00126	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000103	0.00125	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000103	0.00125	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000102	0.00124	CbGpPWpGaD
Darifenacin—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	9.93e-05	0.00121	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—FADS1—Crohn's disease	9.91e-05	0.0012	CbGpPWpGaD
Darifenacin—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	9.51e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR9—Crohn's disease	9.51e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR9—Crohn's disease	9.48e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.47e-05	0.00115	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	9.39e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR9—Crohn's disease	9.39e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	9.36e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCR6—Crohn's disease	9.34e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GPX4—Crohn's disease	9.28e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	9.27e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	9.15e-05	0.00111	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GCKR—Crohn's disease	8.96e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCR6—Crohn's disease	8.95e-05	0.00109	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	8.94e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GPR65—Crohn's disease	8.84e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GPR65—Crohn's disease	8.81e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	8.8e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.79e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	8.78e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.76e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	8.76e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GPR65—Crohn's disease	8.73e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	8.69e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	8.68e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	8.52e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	8.51e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	8.49e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RBX1—Crohn's disease	8.45e-05	0.00103	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	8.41e-05	0.00102	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	8.31e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	8.22e-05	0.000999	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RBX1—Crohn's disease	8.09e-05	0.000982	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL3—Crohn's disease	8e-05	0.000971	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL3—Crohn's disease	7.97e-05	0.000968	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	7.95e-05	0.000966	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL3—Crohn's disease	7.89e-05	0.000958	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	7.88e-05	0.000956	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	7.73e-05	0.000939	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	7.71e-05	0.000936	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	7.63e-05	0.000927	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTMR3—Crohn's disease	7.6e-05	0.000923	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	7.41e-05	0.000899	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	7.18e-05	0.000872	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	7.09e-05	0.000861	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	7.04e-05	0.000855	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL3—Crohn's disease	7e-05	0.000851	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	6.88e-05	0.000835	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	6.78e-05	0.000823	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL3—Crohn's disease	6.71e-05	0.000814	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	6.7e-05	0.000813	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	6.67e-05	0.00081	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.67e-05	0.00081	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	6.65e-05	0.000807	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	6.61e-05	0.000802	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	6.49e-05	0.000788	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCR6—Crohn's disease	6.3e-05	0.000765	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCR6—Crohn's disease	6.28e-05	0.000762	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCR6—Crohn's disease	6.22e-05	0.000755	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	6.17e-05	0.000749	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	6.15e-05	0.000747	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	6.15e-05	0.000747	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	6.14e-05	0.000745	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	6.09e-05	0.000739	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—FADS1—Crohn's disease	5.92e-05	0.000719	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	5.89e-05	0.000715	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	5.88e-05	0.000714	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	5.85e-05	0.000711	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	5.85e-05	0.00071	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RBX1—Crohn's disease	5.7e-05	0.000692	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RBX1—Crohn's disease	5.68e-05	0.000689	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RBX1—Crohn's disease	5.62e-05	0.000683	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	5.61e-05	0.000681	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	5.6e-05	0.000681	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	5.6e-05	0.00068	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	5.58e-05	0.000678	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	5.58e-05	0.000678	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX4—Crohn's disease	5.55e-05	0.000674	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	5.55e-05	0.000673	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	5.53e-05	0.000671	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	5.53e-05	0.000671	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	5.47e-05	0.000665	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	5.37e-05	0.000652	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GCKR—Crohn's disease	5.36e-05	0.000651	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	5.35e-05	0.000649	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	5.3e-05	0.000643	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	5.1e-05	0.000619	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	5.08e-05	0.000616	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	4.99e-05	0.000606	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	4.98e-05	0.000605	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTMR3—Crohn's disease	4.97e-05	0.000604	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	4.93e-05	0.000599	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	4.91e-05	0.000596	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	4.88e-05	0.000592	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	4.84e-05	0.000588	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	4.83e-05	0.000586	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	4.78e-05	0.000581	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL3—Crohn's disease	4.72e-05	0.000573	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL3—Crohn's disease	4.71e-05	0.000572	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	4.7e-05	0.000571	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL3—Crohn's disease	4.66e-05	0.000566	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	4.57e-05	0.000555	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	4.55e-05	0.000553	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	4.51e-05	0.000548	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	4.15e-05	0.000503	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	4.14e-05	0.000503	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	4.13e-05	0.000502	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	4.13e-05	0.000501	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	4.09e-05	0.000497	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	4.09e-05	0.000496	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	3.95e-05	0.000479	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	3.93e-05	0.000478	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	3.9e-05	0.000473	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—FADS1—Crohn's disease	3.87e-05	0.00047	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	3.78e-05	0.000459	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	3.77e-05	0.000458	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	3.76e-05	0.000457	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	3.75e-05	0.000456	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	3.73e-05	0.000453	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	3.72e-05	0.000451	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX4—Crohn's disease	3.63e-05	0.00044	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	3.57e-05	0.000434	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	3.56e-05	0.000432	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	3.53e-05	0.000428	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GCKR—Crohn's disease	3.5e-05	0.000425	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TYK2—Crohn's disease	3.46e-05	0.00042	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	3.44e-05	0.000417	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	3.42e-05	0.000416	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	3.39e-05	0.000412	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TYK2—Crohn's disease	3.31e-05	0.000402	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	3.31e-05	0.000402	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	3.3e-05	0.0004	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JAK2—Crohn's disease	3.3e-05	0.0004	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	3.27e-05	0.000397	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JAK2—Crohn's disease	3.16e-05	0.000383	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	3.01e-05	0.000365	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	2.88e-05	0.00035	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—Crohn's disease	2.86e-05	0.000348	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—Crohn's disease	2.85e-05	0.000346	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—Crohn's disease	2.74e-05	0.000333	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—Crohn's disease	2.49e-05	0.000303	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—Crohn's disease	2.42e-05	0.000294	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TYK2—Crohn's disease	2.33e-05	0.000283	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TYK2—Crohn's disease	2.32e-05	0.000282	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—Crohn's disease	2.32e-05	0.000281	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TYK2—Crohn's disease	2.3e-05	0.000279	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JAK2—Crohn's disease	2.22e-05	0.00027	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JAK2—Crohn's disease	2.22e-05	0.000269	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JAK2—Crohn's disease	2.2e-05	0.000267	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	2.03e-05	0.000246	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	2.02e-05	0.000246	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	2e-05	0.000243	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—Crohn's disease	1.93e-05	0.000234	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—Crohn's disease	1.92e-05	0.000234	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—Crohn's disease	1.91e-05	0.000231	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—Crohn's disease	1.71e-05	0.000207	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—Crohn's disease	1.69e-05	0.000205	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—Crohn's disease	1.63e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—Crohn's disease	1.63e-05	0.000198	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—Crohn's disease	1.62e-05	0.000197	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—Crohn's disease	1.61e-05	0.000196	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—Crohn's disease	1.49e-05	0.000181	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—Crohn's disease	1.14e-05	0.000138	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—Crohn's disease	1.14e-05	0.000138	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—Crohn's disease	1.13e-05	0.000137	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—Crohn's disease	1.11e-05	0.000135	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—Crohn's disease	9.75e-06	0.000118	CbGpPWpGaD
